G1 Therapeutics

G1 Therapeutics' Mission and Focus

G1 Therapeutics is dedicated to developing and delivering next-generation therapies aimed at improving the lives and outcomes of individuals living with cancer. The company is heavily involved in advancing innovative therapies across multiple oncology indications. Their mission is reflective of a commitment to enhancing cancer care through cutting-edge research and development.

G1 Therapeutics' Product: COSELA® (trilaciclib)

G1 Therapeutics has developed COSELA® (trilaciclib), a product currently used in the United States. COSELA® is designed to be administered prior to chemotherapy to help protect bone marrow and reduce the occurrence of myelosuppression. This innovation is critical for patients undergoing cancer treatments, as it can help maintain their quality of life and improve treatment outcomes.

G1 Therapeutics' Clinical Trials and Research

G1 Therapeutics is actively engaged in late-stage clinical trials of its therapies in combination with cytotoxic therapies and/or immunotherapy. The focus includes indications such as triple-negative breast cancer (TNBC) and extensive stage small cell lung cancer. Their Phase 2 trial program aims to inform the design of future pivotal studies across multiple tumor types and treatment combinations. Notably, the company completed a Phase 2, randomized, open-label study of trilaciclib in patients with untreated, locally advanced, or metastatic urothelial carcinoma.

G1 Therapeutics' Partnerships and Collaborations

G1 Therapeutics has established significant collaborations to further the development and commercialization of its therapies. The company collaborates with Simcere Pharmaceutical Group for trilaciclib in Greater China and holds an exclusive license agreement with Genor Biopharma for lerociclib in the Asia-Pacific region. These partnerships expand the reach and potential impact of G1 Therapeutics' innovative cancer treatments.

G1 Therapeutics' Community Engagement and Employee Benefits

G1 Therapeutics is committed to supporting community initiatives, particularly those encouraging young people to pursue careers in STEM fields. The company also supports organizations focused on advancing cancer care. For employees, G1 Therapeutics offers a comprehensive benefits package that includes competitive compensation, health and wellness benefits, and opportunities for professional growth. Additionally, the company has a policy to provide expanded access to investigational agents for patients who may benefit from these treatments.